Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma
18 May 2017
Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma
Circulating tumour cells in melanoma
Novel high risk genes of melanoma
New insights in Merkel cell biology and treatment
Duration of checkpoint inhibitor therapy
PD1/ CTLA4 : Upfront or sequentially?
Brain metastases: a role of conventional chemotherapy?
Deregulated TGF-β superfamily signalling in cancer
The potential of aspirin in the prevention and treatment of cancer
Functions of BRCA1 and the implications for treatment
Genetic determinants of breast cancer immune phenotypes
IMPAKT conference highlights